← FDA Drug Approvals (Drugs@FDA)
TACROLIMUS
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: NEXUS · Approved 2025-02-12
Drug application
- FDA Application #
ANDA217108- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- TACROLIMUS
- Generic name
- TACROLIMUS
- Active ingredients
- TACROLIMUS
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- NEXUS
- Manufacturer
- Nexus Pharmaceuticals, LLC
- First approval
- 2025-02-12
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown